| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Hao Li | Q59749262 |
| Paula Da Fonseca | Q73783916 | ||
| P2093 | author name string | Matthew Bogyo | |
| P2860 | cites work | Spread of artemisinin resistance in Plasmodium falciparum malaria | Q21032481 |
| Inhibitors selective for mycobacterial versus human proteasomes | Q27657451 | ||
| Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution | Q27730197 | ||
| Structure of 20S proteasome from yeast at 2.4 A resolution | Q27735081 | ||
| Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance | Q28546636 | ||
| Proteasome inhibitors block development of Plasmodium spp. | Q33700189 | ||
| Assessing subunit dependency of the Plasmodium proteasome using small molecule inhibitors and active site probes | Q34061291 | ||
| Identification of potent and selective non-covalent inhibitors of the Plasmodium falciparum proteasome | Q34282526 | ||
| 2.8 Å resolution reconstruction of the Thermoplasma acidophilum 20S proteasome using cryo-electron microscopy | Q34466607 | ||
| Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity | Q34473136 | ||
| Measuring the optimal exposure for single particle cryo-EM using a 2.6 Å reconstruction of rotavirus VP6 | Q35646003 | ||
| Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors | Q36237082 | ||
| Structure- and function-based design of Plasmodium-selective proteasome inhibitors | Q36584903 | ||
| 20S proteasome and its inhibitors: crystallographic knowledge for drug development | Q36742369 | ||
| Proteasome inhibitors: an expanding army attacking a unique target | Q37979388 | ||
| Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development | Q38019864 | ||
| Covalent and non-covalent reversible proteasome inhibition | Q38054702 | ||
| Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting | Q38088874 | ||
| Interplay between the virus and the ubiquitin-proteasome system: molecular mechanism of viral pathogenesis | Q38596791 | ||
| Rational Design of Proteasome Inhibitors as Antimalarial Drugs | Q41602192 | ||
| Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core. | Q41604784 | ||
| The Resolution Revolution | Q57806883 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| Plasmodium falciparum | Q311383 | ||
| cryogenic electron microscopy | Q5190506 | ||
| P304 | page(s) | 4238-4243 | |
| P577 | publication date | 2016-07-02 | |
| P1433 | published in | FEBS Journal | Q1388041 |
| P1476 | title | The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria | |
| P478 | volume | 283 |
| Q92563101 | Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents |
| Q40139788 | Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity |
| Q36392578 | High-resolution cryo-EM proteasome structures in drug development. |
| Q39103077 | Targeting proteasomes in infectious organisms to combat disease |
| Q92231044 | The genomic architecture of antimalarial drug resistance |
| Q56380854 | The proteasome as a target to combat malaria: hits and misses |
| Q56346314 | Validation of Babesia proteasome as a drug target |
| Q91153166 | cryoEM-Guided Development of Antibiotics for Drug-Resistant Bacteria |
Search more.